Navigation Links
InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Date:2/17/2010

cepted for review by the FDA, and was granted "Priority Review" status with an expected PDUFA action date of May 4, 2010.
  • On February 1, 2010, we reported that the pirfenidone NDA is scheduled to be discussed at the FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting on March 9, 2010.
  • A Marketing Authorization Application (MAA) for pirfenidone for the treatment of IPF is expected to be submitted to the European Medicines Agency (EMA) in the current quarter.
  • Seven abstracts concerning pirfenidone and IPF have been accepted for presentations at the Annual Meeting of the American Thoracic Society (ATS) in New Orleans, May 14-19, 2010.  

  • RG7227:

    • On January 11, we reported preliminary, top-line results of a Phase 1b multiple-ascending-dose (MAD) study of low doses of once-daily and twice-daily RG7227 co-administered with low-dose ritonavir in combination with standard of care (SOC) for 15 days in treatment-naive HCV-infected patients.  Preliminary data from the first two cohorts of the study indicated that in the presence of SOC, the majority of patients achieved an undetectable level of HCV RNA after 15 days of treatment.  No drug-related serious adverse events have been reported to date.  InterMune and our collaboration partner Roche plan to amend the protocol of the on-going Phase 1b MAD study to evaluate 12 weeks of RG7227 ritonavir-boosted therapy plus SOC.
    • The companies anticipate presenting the results of the MAD ritonavir-boosting study at a medical conference in the first half of 2010, subject to abstract acceptance.
    • Un-blinded 4-week RVR (rapid virologic response) and 12-week EVR (early virologic response) data from the 12-week
      '/>"/>

    SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
    2. InterMune Announces Start of Phase 1b Trial of ITMN-191
    3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
    4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
    5. InterMune Announces Progress on Pirfenidone in IPF
    6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
    7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
    8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
    9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
    10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
    11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... Kan. , July 25, 2014 /PRNewswire-iReach/ -- ... and TCGRx, of Powers Lake, Wisconsin ... partners in a distribution and co-marketing agreement allowing ... retail pharmacies throughout the United States ... robotics-based pharmacy management and workflow systems to retail ...
    (Date:7/25/2014)... , July 25, 2014 Cardinal Health will ... pharmacies as winners of its prestigious Independent Pharmacy Best ... , one of the nation,s largest gatherings of independent ... – family-owned pharmacies from Ohio , ... – were selected for implementing exceptionally creative ...
    (Date:7/25/2014)... DUBLIN , July 25, 2014 ... the "Global Ophthalmic Diagnostic Devices Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 About Ophthalmic Diagnostic Device ... device used to identify a defect or deficiency in ... patients with ophthalmic disorders such as presbyopia, cataracts, glaucoma, ...
    Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
    ... presented at NACFC and ICAAC/IDSA meetings this week, ... Inc. today,announced additional clinical and preclinical results with ... delivered by,an Investigational eFlow Nebulizer System for use ... (COPD). Clinical results show,that aerosol dosing of MP-376 ...
    ... 23 , - First Responses in Solid ... role in cell duplication and are,implicated in both ... tumour. A,lecture focusing on Aurora kinase inhibitors will ... 20th EORTC-NCI-AACR Symposium "Molecular,Targets and Cancer Therapeutics" organised ...
    Cached Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 3
    (Date:7/26/2014)... (PRWEB) July 26, 2014 According to ... Vkool.com, this is a comprehensive guide that covers detailed ... (KP) effectively without the need of any medication. ... consists of natural and safe remedies for relieving symptoms ... people will learn:,     How to treat ...
    (Date:7/26/2014)... The birth control safety center at ... of new legal information on the site. A federal ... of lawsuits pending for July alleging side effects from ... those using popular prescription drugs and medical devices. By ... legal news all in one place, they can see ...
    (Date:7/25/2014)... 2014 2014 Deep Research ... Chromatography Industry” is a professional and in-depth ... Gel Permeation Chromatography market. The report provides ... Permeation Chromatography definition, classification, application, and industry ... This research covers the international market analysis, ...
    (Date:7/25/2014)... According to a new market ... (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, ... and Geography - Global Forecast to 2014 - ... market is expected to reach $2.50 at a ... Browse 117 market data Tables and 57 Figures ...
    (Date:7/25/2014)... July 25, 2014 As reported by the ... War On Heroin (7/20), police in Salem, MA as ... down on the recent heroin epidemic that has taken many ... on one heroin-related overdose case in which police were able ... victim's cell phone. By pretending to be the victim and ...
    Breaking Medicine News(10 mins):Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:DrugNews Adds Latest Court Updates on Mirena IUD Lawsuits 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Multiple States Crack Down on Heroin Epidemic 2
    ... Although it is now common knowledge that breast-feeding gives ... has found that babies who are breast-fed beyond none ... feeding for up to six months is known to ... extending exclusive breast-feeding beyond six months may increase the ...
    ... Caledonian University have found that almost one in 10 ... survey of more than 2,000 students studying //in west-central ... aged between 13-16 demonstrated behaviors that could lead to ... group of 11-12 years, 6 percent of the children ...
    ... Medical School and his team has carried out research on ... occurs only in one in a million births. “About 1,500 ... injections to survive” says Dr. Pearson. According to him neonatal ... will help in controlling the blood sugar levels more effectively. ...
    ... due to its eradication, yet people could still be susceptible ... says a recent report.// ,Researchers recalled the ... an unvaccinated teenager contracted the virus and innocently passed it ... a large outbreak in USA, which also caused a financial ...
    ... released a 10-year ‘action plan’ for improving the services and ... ,It was reported that the N.Zealand, Health Minister Pete Hodgson ... part of the work was to ensure that patients with ... earlier by way of a large range of services. ...
    ... an alarm clock that promises to wake its users up when ... Sleep Phase Alarm Clock checks 30 minutes before the alarm is ... or light phase of sleep, say the manufacturers Infacory Innovations, who ... recently in Munich. ,With the help of a sensor ...
    Cached Medicine News:Health News:Painless Control Of Blood Sugar Levels When Detected Early 2
    ... the art software package designed to assist in ... by a lens manufacturer with years of experience ... is designed to help you run your lab ... the software dictates., ,Designed specifically for integrated retail ...
    ... The table-mounted knee retractor ... for total knee arthroplasty ... open-frame design allows for ... knee during the procedure. ...
    ... for every general surgery need. No matter ... the GO550/GO500 Omni-Flex General Retractor Systems give ... simplest way possible., ,With large and small ... arm, the GO550 provides comprehensive flexibility and ...
    ... sounds you need to hear! ... body sounds while reducing distracting ... Model 3000., ,With Ambient Noise ... 18 times amplification, and a ...
    Medicine Products: